{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T10:36:18Z","timestamp":1785753378541,"version":"3.56.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000942","name":"Brain Foundation","doi-asserted-by":"publisher","award":["1044007"],"award-info":[{"award-number":["1044007"]}],"id":[{"id":"10.13039\/501100000942","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1044007"],"award-info":[{"award-number":["1044007"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.yebeh.2021.108223","type":"journal-article","created":{"date-parts":[[2021,8,10]],"date-time":"2021-08-10T14:19:49Z","timestamp":1628605189000},"page":"108223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Fructose 1,6-bisphosphate is anticonvulsant and improves oxidative glucose metabolism within the hippocampus and liver in the chronic pilocarpine mouse epilepsy model"],"prefix":"10.1016","volume":"122","author":[{"given":"Tanya S.","family":"McDonald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott S.","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2021.108223_b0005","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3389\/fncel.2018.00274","article-title":"Impairments in oxidative glucose metabolism in epilepsy and metabolic treatments thereof","volume":"12","author":"McDonald","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.yebeh.2021.108223_b0010","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.neuropharm.2012.05.012","article-title":"Energy depletion in seizures: anaplerosis as a strategy for future therapies","volume":"69","author":"Kovac","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.yebeh.2021.108223_b0015","first-page":"CD001903","article-title":"Ketogenic diets for drug-resistant epilepsy","volume":"11","author":"Martin-McGill","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.yebeh.2021.108223_b0020","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/157015909789152164","article-title":"Adenosine, ketogenic diet and epilepsy: the emerging therapeutic relationship between metabolism and brain activity","volume":"7","author":"Masino","year":"2009","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.yebeh.2021.108223_b0025","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.brainres.2018.05.049","article-title":"Metabolism and epilepsy: Ketogenic diets as a homeostatic link","volume":"1703","author":"Masino","year":"2019","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2021.108223_b0030","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ejpn.2018.07.014","article-title":"A pilot study of add-on oral triheptanoin treatment for children with medically refractory epilepsy","volume":"22","author":"Calvert","year":"2018","journal-title":"Eur J Paediatr Neurol"},{"key":"10.1016\/j.yebeh.2021.108223_b0035","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/epi4.12308","article-title":"Randomised trial of add-on triheptanoin vs. medium chain triglycerides in adults with refractory epilepsy","volume":"4","author":"Borges","year":"2019","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.yebeh.2021.108223_b0040","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1093\/brain\/awv325","article-title":"Seizure control by decanoic acid through direct AMPA receptor inhibition","volume":"139","author":"Chang","year":"2016","journal-title":"Brain"},{"key":"10.1016\/j.yebeh.2021.108223_b0045","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1177\/0271678X16659498","article-title":"Tridecanoin is anticonvulsant, antioxidant, and improves mitochondrial function","volume":"37","author":"Tan","year":"2017","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.yebeh.2021.108223_b0050","doi-asserted-by":"crossref","unstructured":"Han FY, Conboy-Schmidt L, Rybachuk G, Volk HA, Zanghi B, Pan Y, Borges K. Dietary medium chain triglycerides for management of epilepsy: New data from human, dog, and rodent studies. Epilepsia. 2021. doi: 10.1111\/epi.16972.","DOI":"10.1111\/epi.16972"},{"key":"10.1016\/j.yebeh.2021.108223_b0055","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jamaneurol.2017.3949","article-title":"Treatment outcomes in patients with newly diagnosed epilepsy treated with established and new antiepileptic drugs: A 30-year longitudinal cohort study","volume":"75","author":"Chen","year":"2018","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2021.108223_b0060","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-4886(03)00086-4","article-title":"Neuronal and glial pathological changes during epileptogenesis in the mouse pilocarpine model","volume":"182","author":"Borges","year":"2003","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2021.108223_b0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.nbd.2015.02.004","article-title":"A novel anticonvulsant mechanism via inhibition of complement receptor C5ar1 in murine epilepsy models","volume":"76","author":"Benson","year":"2015","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.yebeh.2021.108223_b0070","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s11064-017-2222-z","article-title":"Animal models of seizures and epilepsy: past, present, and future role for the discovery of antiseizure drugs","volume":"42","author":"L\u00f6scher","year":"2017","journal-title":"Neurochem Res"},{"key":"10.1016\/j.yebeh.2021.108223_b0075","doi-asserted-by":"crossref","first-page":"12007","DOI":"10.1523\/JNEUROSCI.3163-07.2007","article-title":"Fructose-1,6-bisphosphate has anticonvulsant activity in models of acute seizures in adult rats","volume":"27","author":"Lian","year":"2007","journal-title":"J Neurosci"},{"issue":"Suppl 8","key":"10.1016\/j.yebeh.2021.108223_b0080","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1528-1167.2008.01849.x","article-title":"Possible mechanisms for the anticonvulsant activity of fructose-1,6-diphosphate","volume":"49","author":"Stringer","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2021.108223_b0085","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/BF00969690","article-title":"Energy metabolism in hypoxic astrocytes: protective mechanism of fructose-1,6-bisphosphate","volume":"20","author":"Kelleher","year":"1995","journal-title":"Neurochem Res"},{"key":"10.1016\/j.yebeh.2021.108223_b0090","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.phrs.2008.01.008","article-title":"Pharmacokinetics of fructose-1,6-diphosphate after intraperitoneal and oral administration to adult rats","volume":"57","author":"Xu","year":"2008","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.yebeh.2021.108223_b0095","doi-asserted-by":"crossref","first-page":"106500","DOI":"10.1016\/j.eplepsyres.2020.106500","article-title":"The efficacy of fructose-1,6-bisphosphate in suppressing status epilepticus in developing rats","volume":"168","author":"Janicot","year":"2020","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2021.108223_b0100","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.neulet.2010.04.030","article-title":"Fructose-1,6-diphosphate inhibits seizure acquisition in fast hippocampal kindling","volume":"477","author":"Ding","year":"2010","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.yebeh.2021.108223_b0105","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.brainres.2013.09.042","article-title":"Fructose-1,6-diphosphate protects against epileptogenesis by modifying cation-chloride co-transporters in a model of amygdaloid-kindling temporal epilepticus","volume":"1539","author":"Ding","year":"2013","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2021.108223_b0110","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neulet.2008.09.042","article-title":"Oral administration of fructose-1,6-diphosphate has anticonvulsant activity","volume":"446","author":"Lian","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.yebeh.2021.108223_b0115","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3389\/fncel.2018.00168","article-title":"The glycolytic metabolite, fructose-1,6-bisphosphate, blocks epileptiform bursts by attenuating voltage-activated calcium currents in hippocampal slices","volume":"12","author":"Shao","year":"2018","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.yebeh.2021.108223_b0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.eplepsyres.2008.05.001","article-title":"Anticonvulsant profile of a balanced ketogenic diet in acute mouse seizure models","volume":"81","author":"Samala","year":"2008","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2021.108223_b0125","article-title":"Acute seizure tests in epilepsy research: electroshock and chemical induced convulsions in the mouse. Current Protocols","volume":"45","author":"Giardina","year":"2009","journal-title":"Pharmacology"},{"key":"10.1016\/j.yebeh.2021.108223_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2307\/3570549","article-title":"Chemical protection against ionizing radiation I. Sampling methods for screening compounds in radiation protection studies in mice","volume":"7","author":"Kimball","year":"1957","journal-title":"Radiat Res"},{"key":"10.1016\/j.yebeh.2021.108223_b0135","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"10.1016\/j.yebeh.2021.108223_b0140","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/jnc.14275","article-title":"Triheptanoin protects against status epilepticus-induced hippocampal mitochondrial dysfunctions, oxidative stress and neuronal degeneration","volume":"144","author":"Tan","year":"2018","journal-title":"J Neurochem"},{"key":"10.1016\/j.yebeh.2021.108223_b0145","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/0271678X19837380","article-title":"Triheptanoin alters [U-13C6]-glucose incorporation into glycolytic intermediates and increases TCA cycling normalizing the activities of pyruvate dehydrogenase and oxoglutarate dehydrogenase in a chronic epilepsy mouse model","volume":"40","author":"McDonald","year":"2020","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.yebeh.2021.108223_b0150","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-1211(01)00302-3","article-title":"Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy","volume":"47","author":"Barton","year":"2001","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2021.108223_b0155","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/jnr.1221","article-title":"Brain amino acid metabolism and ketosis","volume":"66","author":"Yudkoff","year":"2001","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.yebeh.2021.108223_b0160","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.plefa.2003.07.005","article-title":"Ketogenic diet, brain glutamate metabolism and seizure control","volume":"70","author":"Yudkoff","year":"2004","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.yebeh.2021.108223_b0165","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/jcbfm.2013.54","article-title":"Brain mitochondrial metabolic dysfunction and glutamate level reduction in the pilocarpine model of temporal lobe epilepsy in mice","volume":"33","author":"Smeland","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.yebeh.2021.108223_b0170","doi-asserted-by":"crossref","unstructured":"McDonald TS, Carrasco-Pozo C, Hodson MP, Borges K. Alterations in cytosolic and mitochondrial [U-(13)C]glucose metabolism in a chronic epilepsy mouse model. eNeuro 2017;4:ENEURO.0341-16.2017.","DOI":"10.1523\/ENEURO.0341-16.2017"},{"key":"10.1016\/j.yebeh.2021.108223_b0175","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.eplepsyres.2018.06.004","article-title":"The effect of dichloroacetate in mouse models of epilepsy","volume":"145","author":"Durie","year":"2018","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2021.108223_b0180","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.expneurol.2007.06.021","article-title":"Behavioral alterations in the pilocarpine model of temporal lobe epilepsy in mice","volume":"207","author":"Gr\u00f6ticke","year":"2007","journal-title":"Exp Neurol"},{"key":"10.1016\/j.yebeh.2021.108223_b0185","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1535-7597.2004.42001.x","article-title":"Effects of seizures on autonomic and cardiovascular function","volume":"4","author":"Devinsky","year":"2004","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.yebeh.2021.108223_b0190","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s10286-019-00603-1","article-title":"The autonomic signatures of epilepsy: diagnostic clues and novel treatment avenues","volume":"29","author":"Thijs","year":"2019","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.yebeh.2021.108223_b0195","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.pediatrneurol.2017.09.013","article-title":"Antiepileptic drugs and liver disease","volume":"77","author":"Vidaurre","year":"2017","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2021.108223_b0200","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1161\/01.STR.23.11.1617","article-title":"Fructose-1,6-bisphosphate stabilizes brain intracellular calcium during hypoxia in rats","volume":"23","author":"Bickler","year":"1992","journal-title":"Stroke"},{"key":"10.1016\/j.yebeh.2021.108223_b0205","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0165-3806(02)00615-6","article-title":"Fructose-1,6-biphosphate prevents excitotoxic neuronal cell death in the neonatal mouse brain","volume":"140","author":"Rogido","year":"2003","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.yebeh.2021.108223_b0210","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0006-8993(02)03433-9","article-title":"Activation of the neuroprotective ERK signaling pathway by fructose-1,6-bisphosphate during hypoxia involves intracellular Ca2+ and phospholipase C","volume":"958","author":"Fahlman","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2021.108223_b0215","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.3390\/ijms20092239","article-title":"Fructose-1,6-bisphosphate protects hippocampal rat slices from NMDA excitotoxicity","volume":"20","author":"Yakoub","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.yebeh.2021.108223_b0220","doi-asserted-by":"crossref","first-page":"4396","DOI":"10.2174\/0929867323666161014144250","article-title":"Fructose 1,6-bisphosphate: A summary of its cytoprotective mechanism","volume":"23","author":"Alva","year":"2016","journal-title":"Curr Med Chem"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021004844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505021004844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:42:50Z","timestamp":1761504170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505021004844"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":44,"alternative-id":["S1525505021004844"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108223","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fructose 1,6-bisphosphate is anticonvulsant and improves oxidative glucose metabolism within the hippocampus and liver in the chronic pilocarpine mouse epilepsy model","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2021.108223","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108223"}}